Ratings by Piper Sandler (David Westenberg)
| Date | Company | Symbol | Type | Rating (Past) |
PT (Past) |
Start $ (End $) |
% Chg. | Details |
|---|---|---|---|---|---|---|---|---|
| 6/11/2026 | Waters Corp. | WAT | New Coverage | Neutral (N/A) |
371.15 (358.25) |
-3.48% | Details | |
| 6/11/2026 | Twist Bioscience | TWST | New Coverage | Overweight (N/A) |
70.06 (85.17) |
21.57% | Details | |
| 6/11/2026 | Thermo Fisher Scientific | TMO | New Coverage | Neutral (N/A) |
494.07 (464.01) |
-6.08% | Details | |
| 6/11/2026 | Bio-Techne Corp. | TECH | New Coverage | Neutral (N/A) |
54.41 (55.61) |
2.21% | Details | |
| 6/11/2026 | Danaher | DHR | New Coverage | Neutral (N/A) |
188.41 (178.19) |
-5.42% | Details | |
| 6/11/2026 | Agilent | A | New Coverage | Neutral (N/A) |
135.48 (126.49) |
-6.64% | Details | |
| 5/6/2026 | GRAIL, Inc. | GRAL | Maintain | Neutral (N/A) |
|
Details | ||
| 5/5/2026 | Fulgent Genetics | FLGT | Maintain | Neutral (N/A) |
|
Details | ||
| 4/21/2026 | GeneDx | WGS | Maintain | Overweight (N/A) |
|
Details | ||
| 4/16/2026 | Guardant Health | GH | Maintain | Overweight (N/A) |
|
Details | ||
| 4/10/2026 | GRAIL, Inc. | GRAL | New Coverage | Neutral (N/A) |
50.78 (62.10) |
22.29% | Details | |
| 4/10/2026 | Caris Life Sciences Inc | CAI | New Coverage | Neutral (N/A) |
19.51 (17.31) |
-11.28% | Details | |
| 3/31/2026 | GeneDx | WGS | Maintain | Overweight (N/A) |
|
Details | ||
| 3/16/2026 | BillionToOne Inc | BLLN | Maintain | Overweight (N/A) |
|
Details | ||
| 3/10/2026 | Adeptus Biotechnologies Corp. | ADPT | Maintain | Overweight (N/A) |
|
Details | ||
| 2/24/2026 | GeneDx | WGS | Maintain | Overweight (N/A) |
|
Details | ||
| 2/24/2026 | Neogenomics | NEO | Maintain | Overweight (N/A) |
|
Details | ||
| 2/24/2026 | Laboratory Corporation of America | LH | Maintain | Neutral (N/A) |
|
Details | ||
| 2/24/2026 | Guardant Health | GH | Maintain | Overweight (N/A) |
|
Details | ||
| 2/9/2026 | IDEXX Laboratories | IDXX | Maintain | Neutral (N/A) |
|
Details | ||
| 1/22/2026 | Zoetis Inc. | ZTS | Downgrade | Neutral (Overweight) |
123.24 (75.89) |
-38.42% | Details | |
| 1/22/2026 | Elanco Animal Health | ELAN | Upgrade | Overweight (Neutral) |
24.16 (23.90) |
-1.08% | Details | |
| 1/13/2026 | Adeptus Biotechnologies Corp. | ADPT | Maintain | Overweight (N/A) |
|
Details | ||
| 1/12/2026 | Neogen | NEOG | Maintain | Neutral (N/A) |
|
Details | ||
| 12/15/2025 | Adeptus Biotechnologies Corp. | ADPT | Maintain | Overweight (N/A) |
|
Details | ||
| 12/10/2025 | BillionToOne Inc | BLLN | Maintain | Overweight (N/A) |
|
Details | ||
| 12/1/2025 | BillionToOne Inc | BLLN | New Coverage | Overweight (N/A) |
127.85 (100.72) |
-21.22% | Details | |
| 11/24/2025 | Exact Sciences | EXAS | Downgrade | Neutral (Overweight) |
100.90 (104.91) |
3.97% | Details | |
| 11/11/2025 | 10X Genomics | TXG | Maintain | Neutral (N/A) |
|
Details | ||
| 11/11/2025 | Tempus AI Inc | TEM | Maintain | Neutral (N/A) |
|
Details | ||
| 11/11/2025 | Exact Sciences | EXAS | Maintain | Overweight (N/A) |
|
Details | ||
| 11/11/2025 | Fulgent Genetics | FLGT | Maintain | Neutral (N/A) |
|
Details | ||
| 11/10/2025 | Zoetis Inc. | ZTS | Maintain | Overweight (N/A) |
|
Details | ||
| 11/10/2025 | IDEXX Laboratories | IDXX | Maintain | Neutral (N/A) |
|
Details | ||
| 11/10/2025 | Elanco Animal Health | ELAN | Maintain | Neutral (N/A) |
|
Details | ||
| 11/10/2025 | GeneDx | WGS | Maintain | Overweight (N/A) |
|
Details | ||
| 11/10/2025 | Neogenomics | NEO | Maintain | Overweight (N/A) |
|
Details | ||
| 11/10/2025 | Laboratory Corporation of America | LH | Maintain | Neutral (N/A) |
|
Details | ||
| 11/10/2025 | Guardant Health | GH | Maintain | Overweight (N/A) |
|
Details | ||
| 10/27/2025 | Quest Diagnostics | DGX | Maintain | Neutral (N/A) |
|
Details | ||
| 10/22/2025 | Tempus AI Inc | TEM | Maintain | Neutral (N/A) |
|
Details | ||
| 10/22/2025 | Guardant Health | GH | Maintain | Overweight (N/A) |
|
Details | ||
| 10/16/2025 | Neogen | NEOG | Maintain | Neutral (N/A) |
|
Details | ||
| 10/15/2025 | Adeptus Biotechnologies Corp. | ADPT | Maintain | Overweight (N/A) |
|
Details | ||
| 10/8/2025 | Exact Sciences | EXAS | Maintain | Overweight (N/A) |
|
Details | ||
| 10/3/2025 | Neogenomics | NEO | Maintain | Overweight (N/A) |
|
Details | ||
| 9/11/2025 | GeneDx | WGS | Maintain | Overweight (N/A) |
|
Details | ||
| 9/11/2025 | 10X Genomics | TXG | New Coverage | Neutral (N/A) |
13.50 (32.94) |
144% | Details | |
| 8/11/2025 | Zoetis Inc. | ZTS | Maintain | Overweight (N/A) |
|
Details | ||
| 8/11/2025 | IDEXX Laboratories | IDXX | Maintain | Neutral (N/A) |
|
Details | ||
| 8/11/2025 | Elanco Animal Health | ELAN | Maintain | Neutral (N/A) |
|
Details | ||
| 8/11/2025 | Exact Sciences | EXAS | Maintain | Overweight (N/A) |
|
Details | ||
| 8/7/2025 | Exact Sciences | EXAS | Maintain | Overweight (N/A) |
|
Details | ||
| 8/6/2025 | Adeptus Biotechnologies Corp. | ADPT | Maintain | Overweight (N/A) |
|
Details | ||
| 8/4/2025 | GeneDx | WGS | Maintain | Overweight (N/A) |
|
Details | ||
| 7/28/2025 | Quest Diagnostics | DGX | Maintain | Neutral (N/A) |
|
Details | ||
| 7/9/2025 | GeneDx | WGS | New Coverage | Overweight (N/A) |
85.74 (55.42) |
-35.36% | Details | |
| 7/2/2025 | Zoetis Inc. | ZTS | Maintain | Overweight (N/A) |
|
Details | ||
| 5/12/2025 | Zoetis Inc. | ZTS | Maintain | Overweight (N/A) |
|
Details | ||
| 5/6/2025 | Neogenomics | NEO | Maintain | Overweight (N/A) |
|
Details | ||
| 5/6/2025 | Laboratory Corporation of America | LH | Maintain | Neutral (N/A) |
|
Details | ||
| 5/6/2025 | Guardant Health | GH | Maintain | Overweight (N/A) |
|
Details | ||
| 5/6/2025 | Fulgent Genetics | FLGT | Maintain | Neutral (N/A) |
|
Details | ||
| 5/6/2025 | Adeptus Biotechnologies Corp. | ADPT | Maintain | Overweight (N/A) |
|
Details | ||
| 4/22/2025 | Neogen | NEOG | Maintain | Neutral (N/A) |
|
Details | ||
| 4/14/2025 | Neogen | NEOG | Maintain | Neutral (N/A) |
|
Details | ||
| 3/19/2025 | Neogenomics | NEO | Maintain | Overweight (N/A) |
|
Details | ||
| 3/6/2025 | Elanco Animal Health | ELAN | Maintain | Neutral (N/A) |
|
Details | ||
| 3/4/2025 | Tempus AI Inc | TEM | Maintain | Neutral (N/A) |
|
Details | ||
| 3/4/2025 | Fulgent Genetics | FLGT | Maintain | Neutral (N/A) |
|
Details | ||
| 2/27/2025 | Zoetis Inc. | ZTS | Maintain | Overweight (N/A) |
|
Details | ||
| 2/26/2025 | Neogenomics | NEO | Maintain | Overweight (N/A) |
|
Details | ||
| 2/26/2025 | Guardant Health | GH | Maintain | Overweight (N/A) |
|
Details | ||
| 2/26/2025 | Exact Sciences | EXAS | Maintain | Overweight (N/A) |
|
Details | ||
| 2/20/2025 | Adeptus Biotechnologies Corp. | ADPT | Maintain | Overweight (N/A) |
|
Details | ||
| 2/10/2025 | Laboratory Corporation of America | LH | Maintain | Neutral (N/A) |
|
Details | ||
| 2/10/2025 | Zoetis Inc. | ZTS | Maintain | Overweight (N/A) |
|
Details | ||
| 2/10/2025 | IDEXX Laboratories | IDXX | Maintain | Neutral (N/A) |
|
Details | ||
| 2/3/2025 | Quest Diagnostics | DGX | Maintain | Neutral (N/A) |
|
Details | ||
| 1/21/2025 | Neogen | NEOG | Maintain | Neutral (N/A) |
|
Details | ||
| 1/3/2025 | Guardant Health | GH | Maintain | Overweight (N/A) |
|
Details | ||
| 11/26/2024 | Exact Sciences | EXAS | Maintain | Overweight (N/A) |
|
Details | ||
| 11/12/2024 | Tempus AI Inc | TEM | Maintain | Neutral (N/A) |
|
Details | ||
| 11/6/2024 | Exact Sciences | EXAS | Maintain | Overweight (N/A) |
|
Details | ||
| 10/28/2024 | Quest Diagnostics | DGX | Maintain | Neutral (N/A) |
|
Details | ||
| 10/28/2024 | Laboratory Corporation of America | LH | Maintain | Neutral (N/A) |
|
Details | ||
| 10/1/2024 | Laboratory Corporation of America | LH | New Coverage | Neutral (N/A) |
222.10 (254.43) |
14.56% | Details | |
| 9/27/2024 | Adeptus Biotechnologies Corp. | ADPT | Maintain | Overweight (N/A) |
|
Details | ||
| 9/20/2024 | Elanco Animal Health | ELAN | Maintain | Neutral (N/A) |
|
Details | ||
| 9/12/2024 | Exact Sciences | EXAS | Maintain | Overweight (N/A) |
|
Details | ||
| 8/12/2024 | Tempus AI Inc | TEM | New Coverage | Neutral (N/A) |
38.93 (47.85) |
22.91% | Details | |
| 7/29/2024 | Quest Diagnostics | DGX | Maintain | Neutral (N/A) |
|
Details | ||
| 7/19/2024 | Exact Sciences | EXAS | Maintain | Overweight (N/A) |
|
Details | ||
| 7/1/2024 | Elanco Animal Health | ELAN | Maintain | Neutral (N/A) |
|
Details | ||
| 5/13/2024 | Elanco Animal Health | ELAN | Maintain | Neutral (N/A) |
|
Details | ||
| 4/16/2024 | Zoetis Inc. | ZTS | Maintain | Overweight (N/A) |
|
Details | ||
| 4/15/2024 | Neogen | NEOG | Maintain | Neutral (N/A) |
|
Details | ||
| 3/12/2024 | Elanco Animal Health | ELAN | Maintain | Neutral (N/A) |
|
Details | ||
| 3/6/2024 | Fulgent Genetics | FLGT | Maintain | Neutral (N/A) |
|
Details | ||
| 2/20/2024 | Zoetis Inc. | ZTS | Maintain | Overweight (N/A) |
|
Details | ||
| 1/30/2024 | IDEXX Laboratories | IDXX | Downgrade | Neutral (Overweight) |
524.98 (545.73) |
3.95% | Details | |
| 1/18/2024 | Neogen | NEOG | Maintain | Neutral (N/A) |
|
Details | ||
| 11/13/2023 | Elanco Animal Health | ELAN | Maintain | Neutral (N/A) |
|
Details | ||
| 11/6/2023 | Zoetis Inc. | ZTS | Maintain | Overweight (N/A) |
|
Details | ||
| 11/6/2023 | IDEXX Laboratories | IDXX | Maintain | Overweight (N/A) |
|
Details | ||
| 10/16/2023 | Invitae Corporation | NVTA | Maintain | Underweight (N/A) |
|
Details | ||
| 10/16/2023 | Neogenomics | NEO | Maintain | Overweight (N/A) |
|
Details | ||
| 10/16/2023 | Fulgent Genetics | FLGT | Maintain | Neutral (N/A) |
|
Details | ||
| 10/16/2023 | Exact Sciences | EXAS | Maintain | Overweight (N/A) |
|
Details | ||
| 10/16/2023 | Quest Diagnostics | DGX | Maintain | Neutral (N/A) |
|
Details | ||
| 10/16/2023 | Adeptus Biotechnologies Corp. | ADPT | Maintain | Overweight (N/A) |
|
Details | ||
| 10/10/2023 | Exact Sciences | EXAS | Upgrade | Overweight (Neutral) |
62.70 (100.90) |
60.93% | Details | |
| 9/27/2023 | Guardant Health | GH | Upgrade | Overweight (Neutral) |
26.26 (128.83) |
390.59% | Details | |
| 8/14/2023 | Zoetis Inc. | ZTS | Maintain | Overweight (N/A) |
|
Details | ||
| 8/14/2023 | Elanco Animal Health | ELAN | Maintain | Neutral (N/A) |
|
Details | ||
| 8/8/2023 | Guardant Health | GH | Maintain | Neutral (N/A) |
|
Details | ||
| 8/8/2023 | Exact Sciences | EXAS | Maintain | Neutral (N/A) |
|
Details | ||
| 8/8/2023 | Adeptus Biotechnologies Corp. | ADPT | Maintain | Overweight (N/A) |
|
Details | ||
| 8/7/2023 | Neogen | NEOG | Maintain | Neutral (N/A) |
|
Details | ||
| 6/29/2023 | Quest Diagnostics | DGX | New Coverage | Neutral (N/A) |
142.56 (193.58) |
35.79% | Details | |
| 5/15/2023 | Elanco Animal Health | ELAN | Maintain | Neutral (N/A) |
|
Details | ||
| 5/8/2023 | Zoetis Inc. | ZTS | Maintain | Overweight (N/A) |
|
Details | ||
| 5/8/2023 | Fulgent Genetics | FLGT | Maintain | Neutral (N/A) |
|
Details | ||
| 5/8/2023 | Adeptus Biotechnologies Corp. | ADPT | Maintain | Overweight (N/A) |
|
Details | ||
| 4/11/2023 | Neogen | NEOG | Maintain | Neutral (N/A) |
|
Details | ||
| 12/21/2022 | Adeptus Biotechnologies Corp. | ADPT | Upgrade | Overweight (Neutral) |
7.26 (17.37) |
139.26% | Details | |
| 12/15/2022 | Neogen | NEOG | Maintain | Neutral (N/A) |
|
Details | ||
| 12/8/2022 | Fulgent Genetics | FLGT | Downgrade | Neutral (Overweight) |
36.09 (17.84) |
-50.57% | Details | |
| 11/14/2022 | Neogenomics | NEO | Maintain | Overweight (N/A) |
|
Details | ||
| 11/14/2022 | Fulgent Genetics | FLGT | Maintain | Overweight (N/A) |
|
Details | ||
| 11/14/2022 | Exact Sciences | EXAS | Maintain | Neutral (N/A) |
|
Details | ||
| 11/14/2022 | Elanco Animal Health | ELAN | Maintain | Neutral (N/A) |
|
Details | ||
| 11/1/2022 | Guardant Health | GH | Downgrade | Neutral (Overweight) |
47.86 (128.83) |
169.18% | Details | |
| 10/26/2022 | Adeptus Biotechnologies Corp. | ADPT | Maintain | Neutral (N/A) |
|
Details | ||
| 10/10/2022 | Neogen | NEOG | Maintain | Neutral (N/A) |
|
Details | ||
| 8/17/2022 | Elanco Animal Health | ELAN | Maintain | Neutral (N/A) |
|
Details | ||
| 8/8/2022 | IDEXX Laboratories | IDXX | Maintain | Overweight (N/A) |
|
Details | ||
| 8/1/2022 | Neogen | NEOG | Maintain | Neutral (N/A) |
|
Details | ||
| 7/26/2022 | IDEXX Laboratories | IDXX | Maintain | Overweight (N/A) |
|
Details | ||
| 7/12/2022 | Neogen | NEOG | New Coverage | Neutral (N/A) |
23.39 (8.92) |
-61.86% | Details | |
| 7/12/2022 | IDEXX Laboratories | IDXX | New Coverage | Overweight (N/A) |
378.45 (545.73) |
44.2% | Details | |
| 7/12/2022 | Zoetis Inc. | ZTS | New Coverage | Overweight (N/A) |
177.98 (75.89) |
-57.36% | Details | |
| 7/12/2022 | Elanco Animal Health | ELAN | New Coverage | Neutral (N/A) |
20.45 (23.90) |
16.87% | Details | |
| 6/3/2022 | Adeptus Biotechnologies Corp. | ADPT | New Coverage | Neutral (N/A) |
7.99 (17.37) |
117.4% | Details | |
| 6/3/2022 | Neogenomics | NEO | New Coverage | Overweight (N/A) |
8.05 (11.20) |
39.13% | Details | |
| 6/3/2022 | Invitae Corporation | NVTA | Maintain | Underweight (N/A) |
|
Details | ||
| 6/3/2022 | Exact Sciences | EXAS | New Coverage | Neutral (N/A) |
48.48 (104.91) |
116.4% | Details | |
| 6/3/2022 | Guardant Health | GH | New Coverage | Overweight (N/A) |
38.65 (128.83) |
233.32% | Details | |
| 3/1/2022 | Fulgent Genetics | FLGT | Maintain | Overweight (N/A) |
|
Details | ||
| 2/4/2022 | Fulgent Genetics | FLGT | New Coverage | Overweight (N/A) |
64.97 (17.84) |
-72.54% | Details |
